Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 84.00 | |
5 mg | In stock | $ 197.00 | |
10 mg | In stock | $ 289.00 | |
25 mg | In stock | $ 488.00 | |
50 mg | In stock | Inquiry |
Description | GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM). |
Targets&IC50 | SMYD3:130 nM, SMYD3:14 nM (ki) |
In vitro | GSK2807, a potent and selective, SAM-competitive inhibitor of SMYD3 (Ki = 14 nM). A high-resolution crystal structure reveals that GSK2807 bridges the gap between the SAM-binding pocket and the substrate lysine tunnel of SMYD3. GSK2807 is 24-fold selective for SMYD3 in comparison with the closely related enzyme SMYD2 (Ki=14±6 nM and 345±36 nM, respectively) [1]. |
Molecular Weight | 566.53 |
Formula | C21H33F3N8O7 |
CAS No. | 2245255-66-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL (88.26 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2807 Trifluoroacetate 2245255-66-5 Chromatin/Epigenetic Histone Methyltransferase GSK2807 Inhibitor inhibit GSK 2807 Trifluoroacetate GSK 2807 GSK-2807 GSK-2807 Trifluoroacetate inhibitor